▶ 調査レポート

サルメテロールの世界市場(~2026年)

• 英文タイトル:Global Salmeterol Market Insights and Forecast to 2026

QYResearchが調査・発行した産業分析レポートです。サルメテロールの世界市場(~2026年) / Global Salmeterol Market Insights and Forecast to 2026 / MRC2-11QY09261資料のイメージです。• レポートコード:MRC2-11QY09261
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、111ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はサルメテロールのグローバル市場について調査・分析したレポートです。種類別(喘息、気管支痙攣、COPD、その他)市場規模、用途別(臨床研究所、病院、外科センター、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別サルメテロールの競争状況、市場シェア
・世界のサルメテロール市場:種類別市場規模 2015年-2020年(喘息、気管支痙攣、COPD、その他)
・世界のサルメテロール市場:種類別市場規模予測 2021年-2026年(喘息、気管支痙攣、COPD、その他)
・世界のサルメテロール市場:用途別市場規模 2015年-2020年(臨床研究所、病院、外科センター、その他)
・世界のサルメテロール市場:用途別市場規模予測 2021年-2026年(臨床研究所、病院、外科センター、その他)
・北米のサルメテロール市場分析:米国、カナダ
・ヨーロッパのサルメテロール市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのサルメテロール市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のサルメテロール市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのサルメテロール市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Lupin Limited、MidasCare、Teva Pharmaceutical Industries、GlaxoSmithKline、Intas Pharmaceuticals、NATCO Pharma Limited、INVENT FARMA HOLDING SPAIN、Mylan、Redwing Pharma、Axa Parenterals
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Salmeterol (also known as SEREVENT) is an adrenergic receptor agonist, which is mostly prescribed for the prevention and maintenance of asthma and chronic obstructive pulmonary disease. The drug has a 12-hour duration of action and thus is more beneficial than short-acting beta2- agonists.
The increase in prevalence of people suffering from asthma and COPD, low cost of the drug, and its ability in maintaining the symptoms for long duration of time is expected to increase the demand of the drug. However, certain side-effects of the drug such as dizziness, sinus infection, migraine headaches, and breathing problems restraints the market growth.

Market Analysis and Insights: Global Salmeterol Market
The global Salmeterol market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Salmeterol Scope and Market Size
Salmeterol market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Salmeterol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Salmeterol market is segmented into
Asthma
Bronchospasm
COPD
Others

Segment by Application, the Salmeterol market is segmented into
Clinical Research Institutes
Hospital
Surgical Centers
Others

Regional and Country-level Analysis
The Salmeterol market is analysed and market size information is provided by regions (countries).
The key regions covered in the Salmeterol market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Salmeterol Market Share Analysis
Salmeterol market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Salmeterol business, the date to enter into the Salmeterol market, Salmeterol product introduction, recent developments, etc.

The major vendors covered:
Lupin Limited
MidasCare
Teva Pharmaceutical Industries
GlaxoSmithKline
Intas Pharmaceuticals
NATCO Pharma Limited
INVENT FARMA HOLDING SPAIN
Mylan
Redwing Pharma
Axa Parenterals

レポート目次

1 Study Coverage
1.1 Salmeterol Product Introduction
1.2 Market Segments
1.3 Key Salmeterol Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Salmeterol Market Size Growth Rate by Type
1.4.2 Asthma
1.4.3 Bronchospasm
1.4.4 COPD
1.4.5 Others
1.5 Market by Application
1.5.1 Global Salmeterol Market Size Growth Rate by Application
1.5.2 Clinical Research Institutes
1.5.3 Hospital
1.5.4 Surgical Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Salmeterol Market Size, Estimates and Forecasts
2.1.1 Global Salmeterol Revenue 2015-2026
2.1.2 Global Salmeterol Sales 2015-2026
2.2 Global Salmeterol, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Salmeterol Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Salmeterol Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Salmeterol Competitor Landscape by Players
3.1 Salmeterol Sales by Manufacturers
3.1.1 Salmeterol Sales by Manufacturers (2015-2020)
3.1.2 Salmeterol Sales Market Share by Manufacturers (2015-2020)
3.2 Salmeterol Revenue by Manufacturers
3.2.1 Salmeterol Revenue by Manufacturers (2015-2020)
3.2.2 Salmeterol Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Salmeterol Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Salmeterol Revenue in 2019
3.2.5 Global Salmeterol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Salmeterol Price by Manufacturers
3.4 Salmeterol Manufacturing Base Distribution, Product Types
3.4.1 Salmeterol Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Salmeterol Product Type
3.4.3 Date of International Manufacturers Enter into Salmeterol Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Salmeterol Market Size by Type (2015-2020)
4.1.1 Global Salmeterol Sales by Type (2015-2020)
4.1.2 Global Salmeterol Revenue by Type (2015-2020)
4.1.3 Salmeterol Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Salmeterol Market Size Forecast by Type (2021-2026)
4.2.1 Global Salmeterol Sales Forecast by Type (2021-2026)
4.2.2 Global Salmeterol Revenue Forecast by Type (2021-2026)
4.2.3 Salmeterol Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Salmeterol Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Salmeterol Market Size by Application (2015-2020)
5.1.1 Global Salmeterol Sales by Application (2015-2020)
5.1.2 Global Salmeterol Revenue by Application (2015-2020)
5.1.3 Salmeterol Price by Application (2015-2020)
5.2 Salmeterol Market Size Forecast by Application (2021-2026)
5.2.1 Global Salmeterol Sales Forecast by Application (2021-2026)
5.2.2 Global Salmeterol Revenue Forecast by Application (2021-2026)
5.2.3 Global Salmeterol Price Forecast by Application (2021-2026)

6 North America
6.1 North America Salmeterol by Country
6.1.1 North America Salmeterol Sales by Country
6.1.2 North America Salmeterol Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Salmeterol Market Facts & Figures by Type
6.3 North America Salmeterol Market Facts & Figures by Application

7 Europe
7.1 Europe Salmeterol by Country
7.1.1 Europe Salmeterol Sales by Country
7.1.2 Europe Salmeterol Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Salmeterol Market Facts & Figures by Type
7.3 Europe Salmeterol Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Salmeterol by Region
8.1.1 Asia Pacific Salmeterol Sales by Region
8.1.2 Asia Pacific Salmeterol Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Salmeterol Market Facts & Figures by Type
8.3 Asia Pacific Salmeterol Market Facts & Figures by Application

9 Latin America
9.1 Latin America Salmeterol by Country
9.1.1 Latin America Salmeterol Sales by Country
9.1.2 Latin America Salmeterol Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Salmeterol Market Facts & Figures by Type
9.3 Central & South America Salmeterol Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Salmeterol by Country
10.1.1 Middle East and Africa Salmeterol Sales by Country
10.1.2 Middle East and Africa Salmeterol Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Salmeterol Market Facts & Figures by Type
10.3 Middle East and Africa Salmeterol Market Facts & Figures by Application

11 Company Profiles
11.1 Lupin Limited
11.1.1 Lupin Limited Corporation Information
11.1.2 Lupin Limited Description and Business Overview
11.1.3 Lupin Limited Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Lupin Limited Salmeterol Products Offered
11.1.5 Lupin Limited Related Developments
11.2 MidasCare
11.2.1 MidasCare Corporation Information
11.2.2 MidasCare Description and Business Overview
11.2.3 MidasCare Sales, Revenue and Gross Margin (2015-2020)
11.2.4 MidasCare Salmeterol Products Offered
11.2.5 MidasCare Related Developments
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Corporation Information
11.3.2 Teva Pharmaceutical Industries Description and Business Overview
11.3.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Teva Pharmaceutical Industries Salmeterol Products Offered
11.3.5 Teva Pharmaceutical Industries Related Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Description and Business Overview
11.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline Salmeterol Products Offered
11.4.5 GlaxoSmithKline Related Developments
11.5 Intas Pharmaceuticals
11.5.1 Intas Pharmaceuticals Corporation Information
11.5.2 Intas Pharmaceuticals Description and Business Overview
11.5.3 Intas Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Intas Pharmaceuticals Salmeterol Products Offered
11.5.5 Intas Pharmaceuticals Related Developments
11.6 NATCO Pharma Limited
11.6.1 NATCO Pharma Limited Corporation Information
11.6.2 NATCO Pharma Limited Description and Business Overview
11.6.3 NATCO Pharma Limited Sales, Revenue and Gross Margin (2015-2020)
11.6.4 NATCO Pharma Limited Salmeterol Products Offered
11.6.5 NATCO Pharma Limited Related Developments
11.7 INVENT FARMA HOLDING SPAIN
11.7.1 INVENT FARMA HOLDING SPAIN Corporation Information
11.7.2 INVENT FARMA HOLDING SPAIN Description and Business Overview
11.7.3 INVENT FARMA HOLDING SPAIN Sales, Revenue and Gross Margin (2015-2020)
11.7.4 INVENT FARMA HOLDING SPAIN Salmeterol Products Offered
11.7.5 INVENT FARMA HOLDING SPAIN Related Developments
11.8 Mylan
11.8.1 Mylan Corporation Information
11.8.2 Mylan Description and Business Overview
11.8.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Mylan Salmeterol Products Offered
11.8.5 Mylan Related Developments
11.9 Redwing Pharma
11.9.1 Redwing Pharma Corporation Information
11.9.2 Redwing Pharma Description and Business Overview
11.9.3 Redwing Pharma Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Redwing Pharma Salmeterol Products Offered
11.9.5 Redwing Pharma Related Developments
11.10 Axa Parenterals
11.10.1 Axa Parenterals Corporation Information
11.10.2 Axa Parenterals Description and Business Overview
11.10.3 Axa Parenterals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Axa Parenterals Salmeterol Products Offered
11.10.5 Axa Parenterals Related Developments
11.1 Lupin Limited
11.1.1 Lupin Limited Corporation Information
11.1.2 Lupin Limited Description and Business Overview
11.1.3 Lupin Limited Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Lupin Limited Salmeterol Products Offered
11.1.5 Lupin Limited Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Salmeterol Market Estimates and Projections by Region
12.1.1 Global Salmeterol Sales Forecast by Regions 2021-2026
12.1.2 Global Salmeterol Revenue Forecast by Regions 2021-2026
12.2 North America Salmeterol Market Size Forecast (2021-2026)
12.2.1 North America: Salmeterol Sales Forecast (2021-2026)
12.2.2 North America: Salmeterol Revenue Forecast (2021-2026)
12.2.3 North America: Salmeterol Market Size Forecast by Country (2021-2026)
12.3 Europe Salmeterol Market Size Forecast (2021-2026)
12.3.1 Europe: Salmeterol Sales Forecast (2021-2026)
12.3.2 Europe: Salmeterol Revenue Forecast (2021-2026)
12.3.3 Europe: Salmeterol Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Salmeterol Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Salmeterol Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Salmeterol Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Salmeterol Market Size Forecast by Region (2021-2026)
12.5 Latin America Salmeterol Market Size Forecast (2021-2026)
12.5.1 Latin America: Salmeterol Sales Forecast (2021-2026)
12.5.2 Latin America: Salmeterol Revenue Forecast (2021-2026)
12.5.3 Latin America: Salmeterol Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Salmeterol Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Salmeterol Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Salmeterol Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Salmeterol Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Salmeterol Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Salmeterol Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Salmeterol Market Segments
Table 2. Ranking of Global Top Salmeterol Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Salmeterol Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Asthma
Table 5. Major Manufacturers of Bronchospasm
Table 6. Major Manufacturers of COPD
Table 7. Major Manufacturers of Others
Table 8. Global Salmeterol Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global Salmeterol Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global Salmeterol Sales by Regions 2015-2020 (K Units)
Table 11. Global Salmeterol Sales Market Share by Regions (2015-2020)
Table 12. Global Salmeterol Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Salmeterol Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Salmeterol Sales Share by Manufacturers (2015-2020)
Table 15. Global Salmeterol Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Salmeterol by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Salmeterol as of 2019)
Table 17. Salmeterol Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Salmeterol Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Salmeterol Price (2015-2020) (USD/Unit)
Table 20. Salmeterol Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Salmeterol Product Type
Table 22. Date of International Manufacturers Enter into Salmeterol Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Salmeterol Sales by Type (2015-2020) (K Units)
Table 25. Global Salmeterol Sales Share by Type (2015-2020)
Table 26. Global Salmeterol Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Salmeterol Revenue Share by Type (2015-2020)
Table 28. Salmeterol Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Salmeterol Sales by Application (2015-2020) (K Units)
Table 30. Global Salmeterol Sales Share by Application (2015-2020)
Table 31. North America Salmeterol Sales by Country (2015-2020) (K Units)
Table 32. North America Salmeterol Sales Market Share by Country (2015-2020)
Table 33. North America Salmeterol Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Salmeterol Revenue Market Share by Country (2015-2020)
Table 35. North America Salmeterol Sales by Type (2015-2020) (K Units)
Table 36. North America Salmeterol Sales Market Share by Type (2015-2020)
Table 37. North America Salmeterol Sales by Application (2015-2020) (K Units)
Table 38. North America Salmeterol Sales Market Share by Application (2015-2020)
Table 39. Europe Salmeterol Sales by Country (2015-2020) (K Units)
Table 40. Europe Salmeterol Sales Market Share by Country (2015-2020)
Table 41. Europe Salmeterol Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Salmeterol Revenue Market Share by Country (2015-2020)
Table 43. Europe Salmeterol Sales by Type (2015-2020) (K Units)
Table 44. Europe Salmeterol Sales Market Share by Type (2015-2020)
Table 45. Europe Salmeterol Sales by Application (2015-2020) (K Units)
Table 46. Europe Salmeterol Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Salmeterol Sales by Region (2015-2020) (K Units)
Table 48. Asia Pacific Salmeterol Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Salmeterol Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Salmeterol Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Salmeterol Sales by Type (2015-2020) (K Units)
Table 52. Asia Pacific Salmeterol Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Salmeterol Sales by Application (2015-2020) (K Units)
Table 54. Asia Pacific Salmeterol Sales Market Share by Application (2015-2020)
Table 55. Latin America Salmeterol Sales by Country (2015-2020) (K Units)
Table 56. Latin America Salmeterol Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Salmeterol Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Salmeterol Revenue Market Share by Country (2015-2020)
Table 59. Latin America Salmeterol Sales by Type (2015-2020) (K Units)
Table 60. Latin America Salmeterol Sales Market Share by Type (2015-2020)
Table 61. Latin America Salmeterol Sales by Application (2015-2020) (K Units)
Table 62. Latin America Salmeterol Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Salmeterol Sales by Country (2015-2020) (K Units)
Table 64. Middle East and Africa Salmeterol Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Salmeterol Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Salmeterol Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Salmeterol Sales by Type (2015-2020) (K Units)
Table 68. Middle East and Africa Salmeterol Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Salmeterol Sales by Application (2015-2020) (K Units)
Table 70. Middle East and Africa Salmeterol Sales Market Share by Application (2015-2020)
Table 71. Lupin Limited Corporation Information
Table 72. Lupin Limited Description and Major Businesses
Table 73. Lupin Limited Salmeterol Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. Lupin Limited Product
Table 75. Lupin Limited Recent Development
Table 76. MidasCare Corporation Information
Table 77. MidasCare Description and Major Businesses
Table 78. MidasCare Salmeterol Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. MidasCare Product
Table 80. MidasCare Recent Development
Table 81. Teva Pharmaceutical Industries Corporation Information
Table 82. Teva Pharmaceutical Industries Description and Major Businesses
Table 83. Teva Pharmaceutical Industries Salmeterol Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Teva Pharmaceutical Industries Product
Table 85. Teva Pharmaceutical Industries Recent Development
Table 86. GlaxoSmithKline Corporation Information
Table 87. GlaxoSmithKline Description and Major Businesses
Table 88. GlaxoSmithKline Salmeterol Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. GlaxoSmithKline Product
Table 90. GlaxoSmithKline Recent Development
Table 91. Intas Pharmaceuticals Corporation Information
Table 92. Intas Pharmaceuticals Description and Major Businesses
Table 93. Intas Pharmaceuticals Salmeterol Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Intas Pharmaceuticals Product
Table 95. Intas Pharmaceuticals Recent Development
Table 96. NATCO Pharma Limited Corporation Information
Table 97. NATCO Pharma Limited Description and Major Businesses
Table 98. NATCO Pharma Limited Salmeterol Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. NATCO Pharma Limited Product
Table 100. NATCO Pharma Limited Recent Development
Table 101. INVENT FARMA HOLDING SPAIN Corporation Information
Table 102. INVENT FARMA HOLDING SPAIN Description and Major Businesses
Table 103. INVENT FARMA HOLDING SPAIN Salmeterol Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. INVENT FARMA HOLDING SPAIN Product
Table 105. INVENT FARMA HOLDING SPAIN Recent Development
Table 106. Mylan Corporation Information
Table 107. Mylan Description and Major Businesses
Table 108. Mylan Salmeterol Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Mylan Product
Table 110. Mylan Recent Development
Table 111. Redwing Pharma Corporation Information
Table 112. Redwing Pharma Description and Major Businesses
Table 113. Redwing Pharma Salmeterol Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. Redwing Pharma Product
Table 115. Redwing Pharma Recent Development
Table 116. Axa Parenterals Corporation Information
Table 117. Axa Parenterals Description and Major Businesses
Table 118. Axa Parenterals Salmeterol Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Axa Parenterals Product
Table 120. Axa Parenterals Recent Development
Table 121. Global Salmeterol Sales Forecast by Regions (2021-2026) (K Units)
Table 122. Global Salmeterol Sales Market Share Forecast by Regions (2021-2026)
Table 123. Global Salmeterol Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 124. Global Salmeterol Revenue Market Share Forecast by Regions (2021-2026)
Table 125. North America: Salmeterol Sales Forecast by Country (2021-2026) (K Units)
Table 126. North America: Salmeterol Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Europe: Salmeterol Sales Forecast by Country (2021-2026) (K Units)
Table 128. Europe: Salmeterol Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Asia Pacific: Salmeterol Sales Forecast by Region (2021-2026) (K Units)
Table 130. Asia Pacific: Salmeterol Revenue Forecast by Region (2021-2026) (US$ Million)
Table 131. Latin America: Salmeterol Sales Forecast by Country (2021-2026) (K Units)
Table 132. Latin America: Salmeterol Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Middle East and Africa: Salmeterol Sales Forecast by Country (2021-2026) (K Units)
Table 134. Middle East and Africa: Salmeterol Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 136. Key Challenges
Table 137. Market Risks
Table 138. Main Points Interviewed from Key Salmeterol Players
Table 139. Salmeterol Customers List
Table 140. Salmeterol Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Salmeterol Product Picture
Figure 2. Global Salmeterol Sales Market Share by Type in 2020 & 2026
Figure 3. Asthma Product Picture
Figure 4. Bronchospasm Product Picture
Figure 5. COPD Product Picture
Figure 6. Others Product Picture
Figure 7. Global Salmeterol Sales Market Share by Application in 2020 & 2026
Figure 8. Clinical Research Institutes
Figure 9. Hospital
Figure 10. Surgical Centers
Figure 11. Others
Figure 12. Salmeterol Report Years Considered
Figure 13. Global Salmeterol Market Size 2015-2026 (US$ Million)
Figure 14. Global Salmeterol Sales 2015-2026 (K Units)
Figure 15. Global Salmeterol Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Salmeterol Sales Market Share by Region (2015-2020)
Figure 17. Global Salmeterol Sales Market Share by Region in 2019
Figure 18. Global Salmeterol Revenue Market Share by Region (2015-2020)
Figure 19. Global Salmeterol Revenue Market Share by Region in 2019
Figure 20. Global Salmeterol Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Salmeterol Revenue in 2019
Figure 22. Salmeterol Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Salmeterol Sales Market Share by Type (2015-2020)
Figure 24. Global Salmeterol Sales Market Share by Type in 2019
Figure 25. Global Salmeterol Revenue Market Share by Type (2015-2020)
Figure 26. Global Salmeterol Revenue Market Share by Type in 2019
Figure 27. Global Salmeterol Market Share by Price Range (2015-2020)
Figure 28. Global Salmeterol Sales Market Share by Application (2015-2020)
Figure 29. Global Salmeterol Sales Market Share by Application in 2019
Figure 30. Global Salmeterol Revenue Market Share by Application (2015-2020)
Figure 31. Global Salmeterol Revenue Market Share by Application in 2019
Figure 32. North America Salmeterol Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Salmeterol Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Salmeterol Sales Market Share by Country in 2019
Figure 35. North America Salmeterol Revenue Market Share by Country in 2019
Figure 36. U.S. Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Salmeterol Market Share by Type in 2019
Figure 41. North America Salmeterol Market Share by Application in 2019
Figure 42. Europe Salmeterol Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Salmeterol Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Salmeterol Sales Market Share by Country in 2019
Figure 45. Europe Salmeterol Revenue Market Share by Country in 2019
Figure 46. Germany Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Salmeterol Market Share by Type in 2019
Figure 57. Europe Salmeterol Market Share by Application in 2019
Figure 58. Asia Pacific Salmeterol Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Salmeterol Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Salmeterol Sales Market Share by Region in 2019
Figure 61. Asia Pacific Salmeterol Revenue Market Share by Region in 2019
Figure 62. China Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Salmeterol Market Share by Type in 2019
Figure 85. Asia Pacific Salmeterol Market Share by Application in 2019
Figure 86. Latin America Salmeterol Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Salmeterol Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Salmeterol Sales Market Share by Country in 2019
Figure 89. Latin America Salmeterol Revenue Market Share by Country in 2019
Figure 90. Mexico Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Salmeterol Market Share by Type in 2019
Figure 97. Latin America Salmeterol Market Share by Application in 2019
Figure 98. Middle East and Africa Salmeterol Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Salmeterol Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Salmeterol Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Salmeterol Revenue Market Share by Country in 2019
Figure 102. Turkey Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Salmeterol Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E Salmeterol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Salmeterol Market Share by Type in 2019
Figure 109. Middle East and Africa Salmeterol Market Share by Application in 2019
Figure 110. North America Salmeterol Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. North America Salmeterol Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Salmeterol Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Europe Salmeterol Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Salmeterol Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Asia Pacific Salmeterol Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Salmeterol Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Latin America Salmeterol Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Salmeterol Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Middle East and Africa Salmeterol Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed